The latest Kaiser Health Tracking poll found 72 percent of Americans said pharmaceutical companies have “too much influence” in the nation’s capital. That’s more than Wall Street (69 percent), health insurance companies (66 percent), the National Rifle Association (52 percent), hospital groups (36 percent) and physician groups (30 percent). Large companies (76 percent) topped the list.
The number of Americans who said pharmaceutical companies have “too much influence” was fairly equal across parties (73 percent of Republicans and 65 percent of Democrats).
The poll, conducted March 8-13 among more than 1,200 adults, also found 52 percent of Americans said passing legislation to reduce prescription drug prices should be a “top priority” for President Donald Trump and lawmakers. At the same time, only 39 percent of Americans said they were confident the administration would deliver on doing so.
Read the full poll results here.
More articles on supply chain:
US grants Amazon patent for drones that react to human gestures
California issues cease-and-desist order to subsidiary of AmerisourceBergen: 6 things to know
FDA approves first frontline treatment for advanced Hodgkin lymphoma in 40 years
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
